Published in

Nature Research, Nature Genetics, 4(48), p. 374-386, 2016

DOI: 10.1038/ng.3521

Links

Tools

Export citation

Search in Google Scholar

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

Journal article published in 2016 by Anna von Wachenfeldt, Isabel dos-Santos-Silva, Miguel de la Hoya, Ans M. W. van den Ouweland, Elizabeth J. van Rensburg, Qin Wang, Ian Tomlinson, Thérèse Truong, Chiu-Chen Tseng, Anna H. (Anna) Wu, Hans Wildiers, Cheng Har Yip, Wei Zheng, Robert Winqvist, A. M. W. Van Den Ouweland and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

We analyzed 3,872 common genetic variants across the ESR1 locus (encoding estrogen receptor α) in 118,816 subjects from three international consortia. We found evidence for at least five independent causal variants, each associated with different phenotype sets, including estrogen receptor (ER(+) or ER(-)) and human ERBB2 (HER2(+) or HER2(-)) tumor subtypes, mammographic density and tumor grade. The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of ESR1, RMND1 and CCDC170, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.